Skip to content

Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions

Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions ----- a Multicenter Study in China

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02033980
Enrollment
400
Registered
2014-01-13
Start date
2016-05-31
Completion date
2017-08-31
Last updated
2016-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Polyps

Keywords

narrow band imaging(NBI), NICE classification, colorectal lesions, predicting histology

Brief summary

Recently, a new category classification (NICE classification) using non-magnified NBI has been proposed. We design this multicenter study to evaluate the reliability and validity of the NICE classification in diagnosing colorectal polyps by Chinese endoscopists during both image and real-time process.

Detailed description

Many reports have demonstrated the efficacy of narrow band imaging (NBI) with magnification in predicting the histology and invasion depth of colorectal polyps. In China, however, the magnifying endoscope is not used in some medical centers. Even in centers equipped with this technique, the magnifying colonoscope is not sufficiently used in daily practice. Recently, a simple category classification (NICE classification) using non-magnified NBI has been proposed, which classifies colorectal tumors into types 1-3 based on different characteristics of color, surface pattern, and microvessels. Type-1 is considered an index for hyperplastic lesions, type-2 is an index for adenoma or mucosal/SM scanty invasive carcinoma and type-3 is an index for deep SM invasive carcinoma. The new classification has soon arouse attention and been validated in some centers on the efficacy of differentiating adenomatous and hyperplastic polyps. However, most studies enrolled diminutive polyps less than 5mm and the efficacy of non-magnified NBI in differentiating type-2 and type-3 lesions has not been reported. To promote this simple classification, we design this multicenter study to evaluate the predictive validity and performance characteristics of the non-magnified NBI in diagnosing polyps during both image and real-time process.

Interventions

DEVICENBI

All detected colorectal lesions will be examined by high-definition NBI. For type 2 and type 3 lesions, subsequent magnifying NBI examination will be performed.

Sponsors

Changhai Hospital
CollaboratorOTHER
Peking University People's Hospital
CollaboratorOTHER
Peking Union Medical College Hospital
CollaboratorOTHER
Chinese PLA General Hospital
CollaboratorOTHER
Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients with colorectal lesions during colonoscopy examination * Informed consent available

Exclusion criteria

* Suspect of advanced colorectal cancer * History of colorectal surgery, familial adenomatous polyposis or inflammatory bowel disease * Poor bowel preparation * Patients under unsuitable conditions for examination or treatment, such as acute upper gastrointestinal bleeding, noncorrectable coagulopathy, severe systemic disease, etc

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of NICE classification in histological prediction by gastroenterological fellowswithin two weeks after polypectomyDiagnostic accuracy of gastroenterological fellows using non-magnified NBI according to NICE classification in histological prediction of polyps, compared with histologic examination

Secondary

MeasureTime frameDescription
Diagnostic accuracy of high-definition and magnifying NBI for type 2 and type 3 lesions.two weeks after endoscopical or surgical resectionFor lesions identified as type 2 or type 3, subsequent magnifying NBI examination will be performed by NBI experts. Before that, experts will make their own assessment according to all the images taken by gastroenterological fellows, blind to their diagnosis. Then experts will examine the lesions using magnifying endoscopy with NBI capability and make a new assessment.

Countries

China

Contacts

Primary ContactZhizheng Ge, MD,Ph.D
zhizhengge@aliyun.com86-21-58752345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026